From ESPAC-1 cracking open adjuvant chemotherapy to RASolute-302 breaking pan-KRAS ice — mapping the evolution and 2026 decision landscape of 37 landmark trials cited in NCCN Pancreatic Adenocarcinoma V1.2026, fully PMID-traceable
From ECOG 1594's chemotherapy plateau to SACHI 2026 — tracing the evolution of 111 NSCLC landmark trials cited in current NCCN + CSCO guidelines into the 2026 decision landscape, every PMID traceable.
Walk through 50 years of public databases — by the end, you'll know exactly where to start
Why a clinician built this site